You are here
Grand Round Webinars
If it’s not a chemical imbalance, then what do I have?” An updated account of depression for both patients and practitioners
This presentation will summarize recent findings on the neurobiology of depression, and distill these findings into a narrative form that is more clearly comprehensible to practitioners and patients alike. Updated explanatory models of depression may help patients better understand their own illness, make sense of the symptoms they experience, and make better informed choices about which treatment options to pursue, as neuromodulation treatments enter increasingly widespread use in the community.
December 06, 2022 at 5:00 PMMORE INFOGrand Rounds Webinar
Getting to the Heart of Precision-TMS: Brainmarkers and Heart-Brain Coupling to optimize TMS clinical outcomes.
Given relatively modest remission rates for all antidepressant treatments available, there is a need for approaches that help tailor existing treatments to the individual in order to improve remission rates. In addition, such techniques should be clinically actionable and well validated in blinded out-of-sample validations. Here we introduce the concept of Stratified Psychiatry, that is better suited for implementation in clinical practice, and demonstrate that Brainmarker-I, an EEG biomarker, can successfully help stratify patients between 1-Hz right and 10-Hz left rTMS, as well as for ECT and various other antidepressant treatments, as a clinically actionable stratification marker. Furthermore, a novel update of NCG-TMS called Heart-Brain Coupling is introduced that provides real time evidence of frontal-vagal activation, simply measured using an iPhone app. This technique not only helps identify the right target for frontal-vagal activation, but also provides frontal excitability thresholds (which are known to differ substantially from motor-thresholds).
November 01, 2022 at 12:00 PMMORE INFOGrand Rounds Webinar
- 1 of 6
- next ›